Bosnalijek expands business in Libya
This article was originally published in Scrip
Executive Summary
The main manufacturer of generic pharmaceuticals in Bosnia and Herzegovina, Bosnalijek, is extending its co-operation with Libya. The Libyan government has astake of around 10% in the company and is its third-largest shareholder (Scrip Online, March 7th, 2008).